The human BTG2/TIS21/PC3 gene:: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene

被引:57
作者
Duriez, C
Falette, N
Audoynaud, C
Moyret-Lalle, C
Bensaad, K
Courtois, S
Wang, Q
Soussi, T
Puisieux, A
机构
[1] Ctr Leon Berard, Unite Oncol Mol, INSERM, U453, F-69373 Lyon 08, France
[2] Inst Curie Genotoxicol Tumeurs, F-75248 Paris, France
[3] Fac Pharm, F-69373 Lyon 08, France
关键词
BTG; promoter region; p53 binding site; breast cancer; mutation;
D O I
10.1016/S0378-1119(01)00825-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BTG2/TIS21/PC3 protein is involved in the regulation of G1/S transition of the cell cycle by inhibiting pRb function, suggesting that BTG2/TIS21/PC3 regulation is critical for normal cell growth and proliferation. To understand the regulatory mechanisms for the expression of BTG2/TIS21/PC3 we cloned the human gene. Potential binding sites for several transcription factors were identified in the 5'-flanking region of the gene. Transient expression assays with BTG2/TIS21/PC3 promoter deletions and electrophoretic mobility shift analysis identified a major wild-type p53 response element located -74 to -122 relative to the start codon. This genomic fragment was sufficient to constitute a promoter element in the presence of p53. The BTG2/TIS21/PC3 gene is an antiproliferative gene which maps within a chromosomal segment (1q32) frequently altered in breast adenocarcinomas. However, no mutations of BTG2/TIS21/PC3 were detected in breast cancer cells, suggesting that the inactivation of this gene is not a frequent genetic event during breast carcinogenesis. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 33 条
[11]  
ELDEIRY WS, 1995, CANCER RES, V55, P2910
[12]   Antiproliferative B cell translocation gene 2 protein is downregulated post-transcriptionally as an early event in prostate carcinogenesis [J].
Ficazzola, MA ;
Fraiman, M ;
Gitlin, J ;
Woo, K ;
Melamed, J ;
Rubin, MA ;
Walden, PD .
CARCINOGENESIS, 2001, 22 (08) :1271-1279
[13]  
FLETCHER BS, 1991, J BIOL CHEM, V266, P14511
[14]   Arrest of G1-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription [J].
Guardavaccaro, D ;
Corrente, G ;
Covone, F ;
Micheli, L ;
D'Agnano, I ;
Starace, G ;
Caruso, M ;
Tirone, F .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1797-1815
[15]   Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle [J].
Guehenneux, F ;
Duret, L ;
Callanan, M ;
Bouhas, R ;
Hayette, S ;
Berthet, C ;
Samarut, C ;
Rimokh, R ;
Birot, AM ;
Wang, Q ;
Magaud, JP ;
Rouault, JP .
LEUKEMIA, 1997, 11 (03) :370-375
[16]  
Guillot C, 1996, CLIN CANCER RES, V2, P1439
[17]   p53; From inductive signal to cellular effect [J].
Hansen, R ;
Oren, M .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1997, 7 (01) :46-51
[18]  
HARDYBESSARD AC, 1998, ONCOGENE, V16, P883
[19]   Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division [J].
Iacopetti, P ;
Michelini, M ;
Stuckmann, I ;
Oback, B ;
Aaku-Saraste, E ;
Huttner, WB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4639-4644
[20]   Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases [J].
Ikematsu, N ;
Yoshida, Y ;
Kawamura-Tsuzuku, J ;
Ohsugi, M ;
Onda, M ;
Hirai, M ;
Fujimoto, J ;
Yamamoto, T .
ONCOGENE, 1999, 18 (52) :7432-7441